Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation  R. Tang, G.H.

Slides:



Advertisements
Similar presentations
Crystallization in the Body. rock salt diamond snowflake.
Advertisements

Aragonite Calcite Vaterite.
Octacalcium phosphate (OCP)-based bone substitute materials
Volume 81, Issue 11, Pages (June 2012)
Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models  D.H. Sweet, S.A. Eraly,
Recent advances in the pathophysiology of nephrolithiasis
Medical Stone Management: 35 Years of Advances
Direct nucleation of calcium oxalate dihydrate crystals onto the surface of living renal epithelial cells in culture  John C. Lieske, F. Gary Toback,
Volume 88, Issue 6, Pages (December 2015)
Volume 61, Issue 3, Pages (March 2002)
A. Evan, J. Lingeman, F.L. Coe, E. Worcester  Kidney International 
Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: An in vitro study  Julie M. Fasano, Saeed R. Khan  Kidney International 
Saeed R. Khan, Patricia A. Glenton, Renal Backov, Daniel R. Talham 
Uremia-related vascular calcification: More than apatite deposition
The case ∣ A young woman with abdominal discomfort and a mass
Volume 56, Issue 4, Pages (October 1999)
Calcium-Dependent Facilitation and Graded Deactivation of Store-Operated Calcium Entry in Fetal Skeletal Muscle  Claude Collet, Jianjie Ma  Biophysical.
Volume 69, Issue 12, Pages (June 2006)
Smad7 gene transfer inhibits peritoneal fibrosis
Volume 55, Issue 2, Pages (February 1999)
Volume 68, Issue 4, Pages (October 2005)
Infected kidney cysts Kidney International
Volume 69, Issue 10, Pages (May 2006)
Volume 62, Issue 4, Pages (October 2002)
Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, K. LaPlante, J.R. Asplin 
Volume 93, Issue 6, Pages (September 2007)
Volume 77, Issue 1, Pages (July 1999)
Sequence-Dependent DNA Condensation and the Electrostatic Zipper
Volume 88, Issue 4, Pages (April 2005)
Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals  John C. Lieske, M.D., F. Gary Toback,
Volume 55, Issue 1, Pages (January 1999)
Urinary cystine excretion and capacity in patients with cystinuria
Volume 80, Issue 4, Pages (August 2011)
Phulwinder K Grover, Villis R Marshall, Rosemary L Ryall 
Volume 103, Issue 4, Pages (August 2012)
Volume 53, Issue 6, Pages (June 1998)
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, Marc D. Grynpas, John.
Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats  Andrew P. Evan, Sharon B. Bledsoe, Susan.
Volume 71, Issue 8, Pages (April 2007)
Volume 65, Issue 5, Pages (May 2004)
End-stage renal failure from asymptomatic bilateral ureteric stones
Volume 61, Issue 3, Pages (March 2002)
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Volume 66, Pages S13-S17 (September 2004)
Methotrexate in the urine
Volume 56, Issue 4, Pages (October 1999)
Volume 84, Issue 3, Pages (March 2003)
Volume 74, Issue 7, Pages (October 2008)
Volume 70, Issue 11, Pages (December 2006)
John R. Asplin, Joan H. Parks, Yashushi Nakagawa, Fredric L. Coe, M.D. 
Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models  D.H. Sweet, S.A. Eraly,
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, A.C. Michalenka, K.L.
Fructose intake as a risk factor for kidney stone disease
The third World Kidney Day: Looking back and thinking forward
Volume 72, Issue 1, Pages 8-10 (July 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Volume 53, Issue 4, Pages (April 1998)
Fibroblast growth factor 23: the making of a hormone
Volume 81, Issue 11, Pages (June 2012)
Organ transplantation goes to the movies
Volume 72, Issue 2, Pages (July 2007)
Atherosclerotic renal artery stenosis and reconstruction
Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, M.D., Walter R. Parker,
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Volume 97, Issue 7, Pages (October 2009)
Presentation transcript:

Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation  R. Tang, G.H. Nancollas, J.L. Giocondi, J.R. Hoyer, C.A. Orme  Kidney International  Volume 70, Issue 1, Pages 71-78 (July 2006) DOI: 10.1038/sj.ki.5000424 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 DCC crystallization plots in a mixed solution of calcium phosphate (Sbrushite=1.271) and oxalate (SCOM=1.864). In the seeded section on the left side, 20 mg of brushite seeds are added at 100 min and the growth of this phase is immediately initiated. After a further 35–45 min, COM begins to crystallize. In the nucleation studies (no seed addition), the formation of brushite is first observed after ∼1400 min and the crystallization of COM begins after an additional 100–120 min. However, under identical experimental conditions but in the absence of phosphate, these COM supersaturated solutions (SCOM=1.864) can remain metastable for more than 2 days without precipitation. Thus, the nucleation of COM is induced and promoted by brushite in these experiments. It is also noteworthy that the addition of brushite titrants is dramatically reduced to zero soon after the formation of COM crystallites in the solutions in these studies. These phenomena are reproducible (>8 parallel experiments), and provide strong evidence that COM formation is promoted in the presence of brushite. Kidney International 2006 70, 71-78DOI: (10.1038/sj.ki.5000424) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 SEM and energy-dispersive spectroscopy results for precipitants during the DCC nucleation experiments. (a–c) represent stages of N-I, N-II, and N-III in Figure 1, respectively. Only brushite crystallites are seen in stage N-I and COM crystallites form on the brushite surfaces at N-II. At N-III, energy-dispersive spectroscopy shows that there is no brushite on the surfaces of aggregates but that brushite can be found by X-ray diffraction after grinding, indicating that it is present in the cores. The morphologies of solids at N-IV are similar to those at N-III; however, the brushite peaks are not detected by X-ray diffraction even after grinding (see Figure 3). Kidney International 2006 70, 71-78DOI: (10.1038/sj.ki.5000424) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 X-ray diffraction of precipitated phases at different stages in the DCC nucleation studies, demonstrating that brushite dissolves after it induces COM growth. Kidney International 2006 70, 71-78DOI: (10.1038/sj.ki.5000424) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 SEM and AFM images show the formation of COM near the dissolving brushite surface. (a) SEM at stage SG-II showing numerous small COM crystallites precipitating (arrows) on the dissolving and roughened brushite surfaces. (b–d) AFM deflection images (20 × 20 μm). These images show the effect of oxalate on brushite (010) growth. (b) Brushite surface growing in solution containing 0.6 mM Ca2+ and 60 mM PO44−. The triangular growth hillocks are representative of normal brushite growth. (c and d) The same area as in (b) in a solution containing 0.6 mM Ca2+, 60 mM PO44−, and 1.1 mM C2O42−. Brushite has become undersaturated at this oxalate concentration. (c) Dissolution pit (arrows) formation on the brushite surface occurs at the same time that COM particles are formed in the solution phase. The COM particles in the perfusate appear as streaks during flow. (d) Lower power micrograph of the development of dissolution pit (arrows) on the smooth brushite surface. (e) SEM showing COM particles that settled on the brushite surface after perfusion was stopped at the end of the experiment. Kidney International 2006 70, 71-78DOI: (10.1038/sj.ki.5000424) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 DCC nucleation and crystallization plots in the presence of uric and citric acids show similar features to those inFigures 1 and 2. However, 0.05 mM uric acid promotes both brushite and COM formation. This reduces the induction time for brushite nucleation from ∼13 490 to ∼860 min and the time period between the nucleation of these phases to about 30 min. In contrast, 5.0 × 10−5 M citric acid inhibits both the nucleation of brushite, extending the induction period to about∼ 2900 min, almost double that in the absence of this additive and the delay period between brushite and COM formation to ∼220 min. Kidney International 2006 70, 71-78DOI: (10.1038/sj.ki.5000424) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 (a) In the absence of brushite, the grown COM crystallites are well separated and there is no aggregation such as is seen in kidney stones. (b) However, COM precipitation induced by brushite in the presence of uric acid produces extensively aggregated masses similar to those observed in the renal tract. (c) These COM aggregates are dispersed to some extent by citrate, which also retards the crystal growth of COM. Kidney International 2006 70, 71-78DOI: (10.1038/sj.ki.5000424) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 7 Scheme showing the dynamic process based on preferential association of calcium ions with oxalate to form COM and the release of phosphate from brushite. Kidney International 2006 70, 71-78DOI: (10.1038/sj.ki.5000424) Copyright © 2006 International Society of Nephrology Terms and Conditions